Poblador, Amalia S.

HRN: 20-99-58  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/21/2023
03/28/2023
IV
600mg
Q8
Cutaneous Abscess
Waiting Final Action 
03/22/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
03/22/2023
03/29/2023
CUTANEOUS
Apply To Affected Areas
BID
Cutaneous Abscess
Waiting Final Action 
03/24/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/24/2023
03/30/2023
IV
500 Mg
Q8H
Soft Tissue Infection
Waiting Final Action 
03/25/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/25/2023
04/01/2023
IV
4.5gms
Q8
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: